Genetically engineered cell factories produce glycoengineered vaccines that target antigen presenting cells and alter immunity

Caroline Benedicte Kjærulff Mathiesen

    Publikation: Konferencebidrag uden forlag/tidsskriftAbstraktForskningpeer review

    OriginalsprogEngelsk
    Publikationsdato2017
    StatusUdgivet - 2017
    BegivenhedKeystone Symposia: Emerging Technologies in Vaccine Discovery and Development - Banff, Canada
    Varighed: 28 jan. 20182 feb. 2018

    Konference

    KonferenceKeystone Symposia
    LokationBanff, Canada
    Periode28/01/1802/02/18

    Citationsformater